Compare IBEX & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBEX | ZVRA |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.1M | 472.9M |
| IPO Year | 2017 | 2015 |
| Metric | IBEX | ZVRA |
|---|---|---|
| Price | $30.46 | $8.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $35.00 | $21.71 |
| AVG Volume (30 Days) | 158.9K | ★ 550.2K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.26 | ★ 34.27 |
| EPS | ★ 1.65 | 1.16 |
| Revenue | ★ $558,273,000.00 | $23,612,000.00 |
| Revenue This Year | $13.14 | $333.64 |
| Revenue Next Year | $5.67 | $44.19 |
| P/E Ratio | $18.23 | ★ $7.60 |
| Revenue Growth | ★ 9.77 | N/A |
| 52 Week Low | $21.64 | $6.19 |
| 52 Week High | $42.99 | $13.16 |
| Indicator | IBEX | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.52 | 53.84 |
| Support Level | $27.70 | $8.61 |
| Resistance Level | $30.63 | $9.03 |
| Average True Range (ATR) | 1.00 | 0.36 |
| MACD | 0.38 | 0.02 |
| Stochastic Oscillator | 90.09 | 69.51 |
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.